F12

gene product
This gene encodes coagulation factor XII which circulates in blood as a zymogen. This single chain zymogen is converted to a two-chain serine protease with an heavy chain (alpha-factor XIIa) and a light chain. The heavy chain contains two fibronectin-type domains, two epidermal growth factor (EGF)-like domains, a kringle domain and a proline-rich domain, whereas the light chain contains only a catalytic domain. On activation, further cleavages takes place in the heavy chain, resulting in the production of beta-factor XIIa light chain and the alpha-factor XIIa light chain becomes beta-factor XIIa heavy chain. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then to beta-factor XIIa. The active factor XIIa participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. It activates coagulation factors VII and XI. Defects in this gene do not cause any clinical symptoms and the sole effect is that whole-blood clotting time is prolonged. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
95 antibodies from 15 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELIFIPIHFC
Novus Biologicals
12 antibodies
Abnova Corporation
6 antibodies
Atlas Antibodies
1 antibody
Proteintech Group
2 antibodies
Acris Antibodies GmbH
6 antibodies
Aviva Systems Biology
5 antibodies
GenWay
6 antibodies
Thermo Fisher Scientific Pierce
1 antibody
Creative Biomart
15 antibodies
LifeSpan BioSciences, Inc.
15 antibodies
GeneTex
6 antibodies
antibodies-online
10 antibodies
Molecular Innovations
7 antibodies
Sigma-Aldrich
2 antibodies
Green Mountain Antibodies
1 antibody